The FDA has accepted the filing of the 510(k) premarket notification application for the Xen Glaucoma Treatment System, Allergan announced in a press release. The system includes the Xen45, which is a minimally invasive gelatin shunt, and the Xen injec…
Leading Augmented and Mixed Reality Optical Display Developer Lumus Ltd. Raises $15M to Scale Expansion
RECHOVOT, Israel–(BUSINESS WIRE)–Lumus Ltd., a leading developer of high-end transparent near-to-eye displays for augmented reality (AR), mixed reality (MR) and smart eyewear, announced today that it has received $15 million of funding led by Shanda …
VIDEO: Surgeon rescues eyes from devastating consequences of angle-supported IOLs
This video shows the case of a 34-year-old woman who, 12 years after implantation of angle-supported phakic IOLs developed cataract, iris atrophy, pupil deformation and glaucoma in both eyes. Camille Budo, MD, OSN Europe Edition Board Member, took care of this patient who was referred to him. He removed the phakic IOL, performed cataract surgery with IOL implantation and also implanted an iris prosthesis, allowing the patient to recover vision as well as aesthetic appearance.Surgery was performed under topical anesthesia. Two paracenteses and one mini-incision were performed, and a dispersive (Read more...)
Researchers discover heart drug could reduce diabetes related blindness
Researchers at Queen’s University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes…
Examining the link between adherence and costs in glaucoma care
“Maximizing patient adherence to medication has the potential to reduce the number of surgical interventions required to treat glaucoma, prevent unnecessary vision loss and save the overall health care system money in the long run.”– Alan L. Robin, MD
VIDEO: Corneal epithelial pachymetry ratios for diagnosis of ketatoconus using SD-OCT
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting, Justin M. Roman, MD, MS, discusses the use of spectral-domain OCT corneal epithelial pachymetry ratios for the early diagnosis of keratoconus.